Loading
Byung Ha Lee

Byung Ha Lee, PhD

Chief Business Officer
Huonslab, Co., Ltd.
Dr. Byung Ha Lee is the Chief Business Officer at Huonslab Co., Ltd., S. Korea, where he leverages his extensive 15+ years of experience in biopharmaceutical R&D to drive strategic growth and commercialization initiatives. A highly accomplished scientific executive, Dr. Lee's expertise spans the full drug development lifecycle, with a primary focus on oncology, rare diseases, and immunology. Previously, as Chief Scientific Officer at NeoImmuneTech, Inc., he provided executive leadership for the entire R&D engine, ensuring the integration of translational research into clinical development plans. Dr. Lee is highly skilled in establishing and managing strategic collaborations with major pharmaceutical companies, KOLs, and academic institutions, a capability honed through his previous roles at Genexine and Samsung Biomedical Research Institute, where he also led successful business development initiatives. Dr. Lee holds a Ph.D. in Biomedical Sciences-immunology from the University of Florida, complemented by postdoctoral training at the NIH, USA. He is a data-driven leader with a proven track record of converting scientific innovation into commercial opportunities and building value through strategic alliances. Dr. Lee is a data-driven, results-oriented leader adept at navigating complex challenges, managing resources effectively, and translating innovative science into meaningful therapeutic advancements and strategic business opportunities for Huonslab.
Speaking In

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS